Evaluating the clinical benefit of pembrolizumab as a first-line agent in advanced solid tumors: A comprehensive review.
Article in Journal of Oncology Pharmacy Practice (May 2024)
The most recent citing publications are shown below. View all 50 publications that cite this research output on Dimensions.
Article in Journal of Oncology Pharmacy Practice (May 2024)
Article in Clinical and Translational Oncology (April 2024)
Article in Pharmaceutics (March 2024)